Keio University

Clinical Research on "Regenerative Medicine Using iPS Cell-Derived Neural Progenitor Cells for Subacute Spinal Cord Injury" (Completion of Follow-up Observation)

Publish: March 21, 2025
Public Relations Office

March 21, 2025

Keio University School of Medicine

Keio University Hospital

National Hospital Organization Osaka National Hospital

National Hospital Organization Murayama Medical Center

Keio University Hospital has completed the follow-up observation and collection of evaluation data for all four planned cases in the clinical research of "Regenerative Medicine Using iPS Cell-Derived Neural Progenitor Cells for Subacute Spinal Cord Injury."

Moving forward, we will proceed without delay with the necessary procedures, such as submitting the overall report and its summary to the Minister of Health, Labour and Welfare, based on the provisions of the Act on the Safety of Regenerative Medicine and its enforcement regulations.

Please see below for the full press release.

Press Release (PDF)